Event Brief
Aug 5, 2026 at 9:10 AM ET
Moderna begins Phase 1 trial for Bundibugyo Ebola vaccine
By The BriefBrief
Moderna vaccinated first volunteers in a Phase 1 trial for a Bundibugyo Ebola mRNA vaccine in Canada.
WHO: Moderna
WHAT: Vaccinated first participants in a Phase 1 trial of an mRNA Bundibugyo Ebola vaccine candidate
WHEN: Reported Aug 5, 2026 at 8:31 AM ET
WHERE: Canada
WHY: To evaluate safety, tolerance, and immune response for the Bundibugyo strain of Ebola virus disease, for which there is currently no vaccine
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Hong Kong woman arrested in HK$4.3m crypto scam
Asia-Pacific
Aug 5, 2026 at 9:12 AM ET
UK not actively considering Epstein public inquiry
Europe
Aug 5, 2026 at 9:12 AM ET
Ukraine says air-defense missile deliveries drop in 2026
Europe
Aug 5, 2026 at 9:10 AM ET
Lake Velence shrinking as Hungary faces extreme heat
Lake Velence
Aug 5, 2026 at 9:10 AM ET
Page 10773 of 21451
Same format. Every time.
Continue reading — sign in or create a free account with
